abstract |
The invention relates to compounds having the formula: n nwherein Ar, r, n, X, R 2 , R 2′ , R 3 , and R 5-7 are as defined in the specification, or a pharmaceutically acceptable salt thereof. These compounds have AT 1 receptor antagonist activity and neprilysin inhibition activity. The invention also relates to pharmaceutical compositions comprising such compounds; methods of using such compounds; and a process and intermediates for preparing such compounds. |